Guardant Health Inc (GH)

EBITDA Growth

-22.75%

Quarterly · Period ending:

GH logo

GH EBITDA Growth

Year-over-year change vs the same period a year earlier

Latest reported-22.75%
GH Quarterly EBITDA YoY % (9.44% → -22.75%)
High-resolution chart · PNG

GH ebitda growth history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Guardant Health Inc EBITDA Growth — Quarterly
Period endingEBITDA Growth
-22.7543%
-20.3621%
-19.9615%
14.7616%
2.6209%
18.7759%
43.6642%
-30.5001%
-49.5549%
15.6013%
-37%
51.1775%
72.2171%
-5.9762%
-96.0117%
-49.5703%
-140.6858%
-13.5985%
21.423%
-50.5659%
-98.7819%
-256.4757%
-401.7015%
-475.0535%
-425.5383%
-59.426%
26.9533%
44.8469%
55.7873%
-32.2874%
-70.4649%
22.4514%
-22.6746%
9.4364%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.